Replies to post #391215 on Amarin Corp Plc (AMRN)

[Whalatane]

Failed end zone run ?
We don’t know that
RESPECT and MITIGATE could still confirm to a clinically significant degree EPA at 4 gm doses reduces CV events in at least secondary prevention CAD patients.

Re Epadel
The AHA at the time doubted it would work in a red meat eating US population.
Mochida ? …. FDA wanted them to run liver biopsy studies before approving here ( long time ago but best as I recall )

Kiwi

[Whalatane]

T is your view that Vascepa does not reduce CV events in at least the secondary prevention population. ?

Not sure of your view sometimes

Kiwi